Skip to main content

Table 1 seAFOod polyp prevention trial treatment allocation

From: A randomized controlled trial of eicosapentaenoic acid and/or aspirin for colorectal adenoma prevention during colonoscopic surveillance in the NHS Bowel Cancer Screening Programme (The seAFOod Polyp Prevention Trial): study protocol for a randomized controlled trial

Placebo

Placebo

EPA-FFA 1 g twice daily

Placebo

Placebo

Aspirin 300 mg once daily

EPA-FFA 1 g twice daily

Aspirin 300 mg once daily

Back to article page

Trials

ISSN: 1745-6215